Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	304.96	193.51	291.05	201.53	246.49
Short-Term Investments	107.53	-	-	-	-
Cash & Short-Term Investments	412.5	193.51	291.05	201.53	246.49
Cash Growth	113.16%	-33.51%	44.42%	-18.24%	-29.74%
Receivables	86.37	84.08	64.07	110.71	93.93
Inventory	33.73	40.74	55.9	-	-
Prepaid Expenses	21.06	21.63	29.56	1.37	1.64
Other Current Assets	0.66	4.26	2.93	0.07	-
Total Current Assets	554.31	344.22	443.51	313.67	342.06
Property, Plant & Equipment	2.97	3.02	3.44	0.11	0.03
Long-Term Investments	393.96	560.98	403.01	483.85	438.26
Goodwill	17.91	17.91	26.71	-	-
Other Intangible Assets	208.43	230.34	252.92	-	-
Long-Term Deferred Tax Assets	12.05	-	-	17.33	93.76
Long-Term Deferred Charges	69.96	83.78	97.61	111.43	125.25
Other Long-Term Assets	41.48	3.27	4.3	0.01	0.21
Total Assets	1,301	1,244	1,231	926.4	999.57
Accounts Payable	2.13	6.72	2.94	0.03	0.07
Accrued Expenses	27.49	28.93	29.63	5.67	6.04
Current Portion of Long-Term Debt	198.47	-	98.83	-	-
Current Portion of Leases	1.57	1.21	1.32	0.11	-
Current Income Taxes Payable	-	-	0.15	-	-
Current Unearned Revenue	1.13	1.28	2.09	-	-
Other Current Liabilities	5.3	-	-	-	-
Total Current Liabilities	236.08	38.13	134.97	5.81	6.11
Long-Term Debt	319.41	516.11	512.13	394.65	385.52
Long-Term Leases	1.18	1.64	2.38	-	0.11
Long-Term Deferred Tax Liabilities	-	0.56	5.77	-	-
Other Long-Term Liabilities	53.23	12.11	10.47	-	-
Total Liabilities	609.9	568.55	665.71	400.46	391.73
Common Stock	0.63	0.63	0.69	0.7	1.01
Additional Paid-In Capital	692.33	1,093	1,164	1,264	1,261
Retained Earnings	-1.8	-25.19	-204.91	-456.15	-722
Treasury Stock	-	-393.83	-393.83	-393.83	-
Total Common Equity	691.16	674.96	565.79	414.74	539.91
Minority Interest	-	-	-	111.19	67.93
Shareholders' Equity	691.16	674.96	565.79	525.94	607.84
Total Liabilities & Equity	1,301	1,244	1,231	926.4	999.57
Total Debt	520.63	518.95	614.65	394.76	385.62
Net Cash (Debt)	-108.13	-325.44	-323.6	-193.23	-139.14
Net Cash Per Share	-1.46	-3.75	-3.40	-2.05	-1.23
Filing Date Shares Outstanding	62.68	63.23	68.13	69.57	101.39
Total Common Shares Outstanding	62.67	63.31	69.19	69.57	101.39
Working Capital	318.22	306.09	308.54	307.87	335.95
Book Value Per Share	11.03	10.66	8.18	5.96	5.32
Tangible Book Value	464.82	426.72	286.16	414.74	539.91
Tangible Book Value Per Share	7.42	6.74	4.14	5.96	5.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q